Christopher Stevenson Email & Phone Number
@jnj.com
3 phones found area 973 and 650
LinkedIn matched
Who is Christopher Stevenson? Overview
A concise factual answer block for searchers comparing this professional profile.
Christopher Stevenson is listed as Chief Scientific Officer, Engitix at Engitix Therapeutics, based in London, England, United Kingdom. AeroLeads shows a work email signal at jnj.com, phone signal with area code 973, 650, and a matched LinkedIn profile for Christopher Stevenson.
Christopher Stevenson previously worked as Chief Scientific Officer at Engitix Therapeutics and Vice President, Global Head Pharmaceutical Sciences, Interventional Oncology at Johnson & Johnson at Johnson & Johnson. Christopher Stevenson holds Phd, Pharmacology from Uc Santa Barbara.
Email format at Engitix Therapeutics
This section adds company-level context without repeating Christopher Stevenson's masked contact details.
AeroLeads found 1 current-domain work email signal for Christopher Stevenson. Compare company email patterns before reaching out.
About Christopher Stevenson
Christopher Stevenson is a Chief Scientific Officer, Engitix at Engitix Therapeutics. He possess expertise in asthma, copd, western blotting, drug development, in vitro and 12 more skills.
Listed skills include Asthma, Copd, Western Blotting, Drug Development, and 13 others.
Christopher Stevenson's current company
Company context helps verify the profile and gives searchers a useful next step.
Christopher Stevenson work experience
A career timeline built from the work history available for this profile.
Vice President, Global Head Pharmaceutical Sciences, Interventional Oncology At Johnson & Johnson
Venture Leader, Copd & Lung Cancer, Disease Interception Accelerator
Led a DIA venture focused on developing technologies to enable early detection and treatment of individuals at risk for developing COPD or lung cancer to prevent/intercept disease processes.Disease Interception (DI) is a Janssen strategy intended to create a paradigm shift from disease care to health care by initiating an evolution from the diagnosis and.
Head Of Respiratory Discovery, Senior Scientific Director
Led the Respivert & Janssen pulmonary discovery strategy and portfolio. Discovery representative on all Respivert clinical development teams and was responsible for biomarker strategies in early clinical studies.
Honorary Professor In Chronic Obstructive Pulmonary Disease
Head Of Biology, Senior Scientific Director
Honorary Lecturer, Respiratory Pharmacology
Preclinical respiratory in vivo pharmacology and translational biology. Respiratory Pharmacology Group, Pharmacology and Toxicology Section, Centre of Integrative Mammalian Physiology and Pharmacology, Centre of Respiratory Infections, National Heart and Lung Institute, Imperial College London.
Lecturer, Respiratory Pharmacology
Preclinical respiratory in vivo pharmacology and translational biology. Respiratory Pharmacology Group, Pharmacology and Toxicology Section, Centre of Integrative Mammalian Physiology and Pharmacology, Centre of Respiratory Infections, National Heart and Lung Institute, Imperial College London.
Translational Biology Unit Head
Lead a multi-disciplinary team of immunologists, pharmacologists, and bioinformaticians Phase 0 clinical studies aiming to define sub-phenotypes of chronic respiratory diseases by integrating clinical phenotyping data with genomic & molecular profiling data.Define translational utility of preclinical (in vivo and in vitro) systems using integrative.
Research Leader, Respiratory Pharmacology & Translational Biology
Preclinical respiratory in vivo & in vitro pharmacologyAsthma, COPD and IPF translational biologyInflammation BiologyInflammation Disease Therapeutic AreaDrug discoveryInhalation pharmacology & drug development
Research Investigator, Respiratory Pharmacology
Preclinical respiratory in vivo pharmacology and translational biology. COPD and airway pharmacology researchRespiratory In Vivo Pharmacology UnitRespiratory Disease Area
Christopher Stevenson education
-
Uc Santa Barbara
Frequently asked questions about Christopher Stevenson
Quick answers generated from the profile data available on this page.
What company does Christopher Stevenson work for?
Christopher Stevenson works for Engitix Therapeutics.
What is Christopher Stevenson's role at Engitix Therapeutics?
Christopher Stevenson is listed as Chief Scientific Officer, Engitix at Engitix Therapeutics.
What is Christopher Stevenson's email address?
AeroLeads has found 1 work email signal at @jnj.com for Christopher Stevenson at Engitix Therapeutics.
What is Christopher Stevenson's phone number?
AeroLeads has found 3 phone signal(s) with area code 973, 650 for Christopher Stevenson at Engitix Therapeutics.
Where is Christopher Stevenson based?
Christopher Stevenson is based in London, England, United Kingdom while working with Engitix Therapeutics.
What companies has Christopher Stevenson worked for?
Christopher Stevenson has worked for Engitix Therapeutics, Johnson & Johnson, The Janssen Pharmaceutical Companies Of Johnson & Johnson, University Of Southern Denmark, and Respivert, Ltd..
How can I contact Christopher Stevenson?
You can use AeroLeads to view verified contact signals for Christopher Stevenson at Engitix Therapeutics, including work email, phone, and LinkedIn data when available.
What schools did Christopher Stevenson attend?
Christopher Stevenson holds Phd, Pharmacology from Uc Santa Barbara.
What skills is Christopher Stevenson known for?
Christopher Stevenson is listed with skills including Asthma, Copd, Western Blotting, Drug Development, In Vitro, In Vivo, Translational Research, and Physiology.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial